Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Salmons

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Trends in Molecular Medicine|June 29, 2001
Novel clinical strategies for the treatment of pancreatic carcinomaW H Günzburg, B Salmons
Virology|November 1, 1986
Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cellsW H Günzburg, B Salmons
Molecular Medicine Today|April 27, 2000
Xenotransplantation: is the risk of viral infection as great as we thought?W H Günzburg, B Salmons
Human Gene Therapy|April 1, 1993
Targeting of retroviral vectors for gene therapyB Salmons, W H Günzburg
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1996
Development of retroviral vectors as safe, targeted gene delivery systemsW H Günzburg, B Salmons
Molecular Medicine Today|December 1, 1995
Virus vector design in gene therapyW H Günzburg, B Salmons
The EMBO Journal|October 1, 1986
The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTRR Jaggi, B Salmons, D Muellener, et al.
Journal of Virology|August 8, 1998
CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectorsJ G Baumann, W H Günzburg, B Salmons
Gene Therapy|April 11, 2000
Accurate estimation of transduction efficiency necessitates a multiplex real-time PCRD Klein, B Bugl, W H Günzburg, et al.
Cytokines and Molecular Therapy|September 1, 1996
Retroviral vector targeting for gene therapyW H Günzburg, A Fleuchaus, R Saller, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Trends in Molecular Medicine|June 29, 2001
Novel clinical strategies for the treatment of pancreatic carcinomaW H Günzburg, B Salmons
Virology|November 1, 1986
Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cellsW H Günzburg, B Salmons
Molecular Medicine Today|April 27, 2000
Xenotransplantation: is the risk of viral infection as great as we thought?W H Günzburg, B Salmons
Human Gene Therapy|April 1, 1993
Targeting of retroviral vectors for gene therapyB Salmons, W H Günzburg
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1996
Development of retroviral vectors as safe, targeted gene delivery systemsW H Günzburg, B Salmons
Molecular Medicine Today|December 1, 1995
Virus vector design in gene therapyW H Günzburg, B Salmons
The EMBO Journal|October 1, 1986
The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTRR Jaggi, B Salmons, D Muellener, et al.
Journal of Virology|August 8, 1998
CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectorsJ G Baumann, W H Günzburg, B Salmons
Gene Therapy|April 11, 2000
Accurate estimation of transduction efficiency necessitates a multiplex real-time PCRD Klein, B Bugl, W H Günzburg, et al.
Cytokines and Molecular Therapy|September 1, 1996
Retroviral vector targeting for gene therapyW H Günzburg, A Fleuchaus, R Saller, et al.
Pageof 6